Malaria Treatment Guidelines

Introduction to G6PD Deficiency

G6PD deficiency is a condition that requires careful management, particularly when using certain medications like dapsone, which can cause hemolysis in affected individuals, as noted by the American Academy of Dermatology 1
Quantitative enzyme activity testing is recommended for diagnosis of G6PD deficiency, with indications including before administering primaquine for malaria, patients with unexplained hemolysis, and individuals from high-prevalence regions, as recommended by the American College of Physicians 2

Point-of-care rapid diagnostic tests have a sensitivity of ~100% for severe/moderate deficiency, and are useful for screening, with similar performance to the fluorescent spot test (FST) 2, 3
The FST is a widely used screening method, with results interpretation including:
Result Interpretation
Absent fluorescence Severe deficiency
Intermediate fluorescence Partial deficiency
Bright fluorescence Normal activity
4, 3

The American Society of Hematology recommends avoiding antibiotics with high oxidative potential, such as sulfonamides, nitrofurantoin, and dapsone, which can trigger hemolytic crises, and instead using penicillins, cephalosporins, macrolides, and most tetracyclines as safe first-line options in patients with G6PD deficiency 2
Dapsone can cause significant hemolysis in G6PD-deficient individuals and requires close monitoring, according to the American Academy of Pediatrics 2
Tetracyclines are generally safe, but should be avoided in children <8 years, as recommended by the Centers for Disease Control and Prevention 5
Sulfonamides, including sulfamethoxazole/cotrimoxazole, require caution when used in G6PD-deficient individuals, although recent evidence suggests a lower risk of hemolysis than previously thought 2
Methylene blue is contraindicated in G6PD deficiency patients, and ascorbic acid (0.5-1.0 g/day in divided doses) can be used instead to treat methemoglobinemia, as recommended by the American Journal of Hematology 6, 4, 7

The Centers for Disease Control and Prevention recommends avoiding primaquine in patients with severe G6PD deficiency, and for those with mild to moderate G6PD deficiency, primaquine should be used with caution, including assessing risks and benefits, checking baseline hematocrit and hemoglobin, and monitoring hematological parameters closely 8
The Centers for Disease Control and Prevention recommends avoiding primaquine in G6PD-deficient patients 6
For P. falciparum malaria, artesunate is preferred over quinine due to quinine's higher risk of hemolysis 6
Malaria treatment guidelines recommend intravenous artesunate as the first-line treatment for severe malaria, with a dosing regimen of 2.4 mg/kg IV at 0, 12, and 24 hours, then daily for up to 7 days, as recommended by guidelines 6
Intravenous quinine is the second-line alternative for severe malaria treatment, with a dosing regimen of 20 mg salt/kg loading dose over 4 hours, followed by 10 mg/kg over 4 hours starting 8 hours after initiation, then every 8 hours 6

Monitoring for signs of hemolysis, including darkening of urine, pallor, and fatigue, is crucial during high-risk situations, such as infection or medication exposure, as recommended by the American Medical Association 2
Discontinuing the offending agent immediately and providing supportive care, including intravenous hydration and blood transfusion for severe anemia, is essential in cases of hemolysis, according to the American Red Cross 2
Patients with G6PD deficiency should be monitored with serial hemoglobin measurements to track hemolysis, and healthcare providers should document G6PD status prominently in medical records and establish a monitoring protocol for high-risk situations, as recommended by the American Journal of Hematology 4

Fava beans are a common dietary trigger for hemolysis in G6PD-deficient individuals and should be avoided, as reported by the American Journal of Hematology 2, 9, 10
Maintaining adequate hydration, especially during illness, is important for preventing hemolysis, as recommended by the National Institutes of Health 2
A diet with 60-70% calories from complex carbohydrates, 10-15% from protein, and remaining from fat is recommended, and individualized nutritional plans should be based on patient preferences and nutritional needs, as suggested by the American College of Medical Genetics and Genomics and the American Diabetes Association 11, 12
Regular physical activity is recommended as part of comprehensive obesity management, and physical activity alone typically causes less weight loss (2-3 kg) but is important for weight maintenance, as reported by the American Diabetes Association and the American Medical Association 11, 13

Pregnant women with G6PD deficiency should avoid primaquine due to the risk to the fetus, as recommended by the American College of Obstetricians and Gynecologists 2
Breastfeeding women should avoid primaquine or discontinue nursing, as recommended by the World Health Organization 2
Newborns from high-risk populations should be screened for G6PD deficiency, as recommended by the Centers for Disease Control and Prevention 2
Heterozygous females with G6PD deficiency may have intermediate deficiency that can still cause clinical symptoms under severe oxidative stress, and timing of testing should be considered, as recommended by the American Journal of Hematology 4
Pediatric patients with G6PD deficiency require careful monitoring for neonatal jaundice and dose adjustment of medications, although specific guidelines are not provided in the citations 4